September 30, 2020 Clinical data focus for the smallest players Our final look at upcoming catalysts sees data expected from Replimune, TCR2 Therapeutics, Anavex and more.
November 29, 2019 Upcoming events – Kalvista aims for acuity and a me-too from Sanofi approaches As Kalvista hopes to attract Merck & Co, Sanofi plays catch-up with Genmab.
August 20, 2019 Where now for Oxurion? The failure of its lead product in diabetic macular oedema, a limited pipeline and limited cash leaves Oxurion with few options.
May 24, 2019 Upcoming events – key tests approach for Biogen and Kalvista Biogen needs a win with its Tecfidera follow-on, while Kalvista hopes to make HAE where Biocryst failed.